DDX17
Probable ATP-dependent RNA helicase DDX17
Also known as: DDX17_HUMAN, P72
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92841
- Gene
- DDX17
- Ensembl
- ENSG00000100201
- Chromosome
- 22
- Canonical length
- 729 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure, such as translation initiation, nuclear and mitochondrial splicing, and ribosome and splicesosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene encodes a DEAD box protein, which is an ATPase activated by a variety of RNA species, but not by dsDNA. This protein, and that encoded by DDX5 gene, are more closely related to each other than to any other member of the DEAD box family. This gene can encode multiple isoforms due to both alternative splicing and the use of alternative translation initiation codons, including a non-AUG (CUG) start codon. [provided by RefSeq, Apr 2011]
Canonical amino-acid sequenceUniProt
729 residues, UniProt reviewed canonical sequence.
>Q92841|DDX17
1 MPTGFVAPIL CVLLPSPTRE AATVASATGD SASERESAAP AAAPTAEAPP PSVVTRPEPQ
61 ALPSPAIRAP LPDLYPFGTM RGGGFGDRDR DRDRGGFGAR GGGGLPPKKF GNPGERLRKK
121 KWDLSELPKF EKNFYVEHPE VARLTPYEVD ELRRKKEITV RGGDVCPKPV FAFHHANFPQ
181 YVMDVLMDQH FTEPTPIQCQ GFPLALSGRD MVGIAQTGSG KTLAYLLPAI VHINHQPYLE
241 RGDGPICLVL APTRELAQQV QQVADDYGKC SRLKSTCIYG GAPKGPQIRD LERGVEICIA
301 TPGRLIDFLE SGKTNLRRCT YLVLDEADRM LDMGFEPQIR KIVDQIRPDR QTLMWSATWP
361 KEVRQLAEDF LRDYTQINVG NLELSANHNI LQIVDVCMES EKDHKLIQLM EEIMAEKENK
421 TIIFVETKRR CDDLTRRMRR DGWPAMCIHG DKSQPERDWV LNEFRSGKAP ILIATDVASR
481 GLDVEDVKFV INYDYPNSSE DYVHRIGRTA RSTNKGTAYT FFTPGNLKQA RELIKVLEEA
541 NQAINPKLMQ LVDHRGGGGG GGGRSRYRTT SSANNPNLMY QDECDRRLRG VKDGGRRDSA
601 SYRDRSETDR AGYANGSGYG SPNSAFGAQA GQYTYGQGTY GAAAYGTSSY TAQEYGAGTY
661 GASSTTSTGR SSQSSSQQFS GIGRSGQQPQ PLMSQQFAQP PGATNMIGYM GQTAYQYPPP
721 PPPPPPSRKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DDX17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 317 nTPM
Expression across tissuesHPA
Tissue
- retina: 317 nTPM
- pituitary gland: 300 nTPM
- ovary: 293 nTPM
- thyroid gland: 291 nTPM
- spleen: 284 nTPM
- cervix: 254 nTPM
Single-cell type
- pituitary stem cells: 916 nCPM
- neutrophils: 911 nCPM
- podocytes: 885 nCPM
- pituicytes/fscs: 881 nCPM
- lactotrophs: 814 nCPM
- thyrotrophs: 790 nCPM
Immune cell
- neutrophil: 17 nTPM
- plasmacytoid DC: 11 nTPM
- eosinophil: 9.6 nTPM
- T-reg: 9.2 nTPM
- memory B-cell: 9 nTPM
- MAIT T-cell: 8.9 nTPM
Brain region
- white matter: 246 nTPM
- choroid plexus: 213 nTPM
- basal ganglia: 176 nTPM
- medulla oblongata: 169 nTPM
- hypothalamus: 161 nTPM
- cerebral cortex: 161 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DDX17.
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 38 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.87
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alternative mRNA splicing, via spliceosome
- androgen receptor signaling pathway
- defense response to virus
- epithelial to mesenchymal transition
- estrogen receptor signaling pathway
- immune system process
- miRNA metabolic process
- myoblast differentiation
- positive regulation of transcription by RNA polymerase II
- regulation of alternative mRNA splicing, via spliceosome
- regulation of skeletal muscle cell differentiation
- regulation of transcription by RNA polymerase II
- regulatory ncRNA-mediated gene silencing
- RNA processing
- rRNA processing
Molecular functions
- ATP binding
- ATP hydrolysis activity
- ATP-dependent activity, acting on RNA
- mRNA binding
- RNA binding
- RNA helicase activity
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATP-dependent RNA helicase DEAD-box, conserved site
- Helicase, C-terminal domain-like
- DEAD/DEAH-box helicase domain
- Helicase superfamily 1/2, ATP-binding domain
- RNA helicase, DEAD-box type, Q motif
- P-loop containing nucleoside triphosphate hydrolase
- DEAD/DEAH box helicase
- Helicase conserved C-terminal domain
- DEAD box protein 17, ATP-binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DDX17 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DDX17 as an antibody target. Whether an autoantibody or antibody against DDX17 could matter depends on whether native DDX17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DDX17 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DDX17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...